Related Experiment Video

Updated: Mar 30, 2026

In Vitro Assay to Evaluate the Impact of Immunoregulatory Pathways on HIV-specific CD4 T Cell Effector Function
09:26

In Vitro Assay to Evaluate the Impact of Immunoregulatory Pathways on HIV-specific CD4 T Cell Effector Function

Published on: October 15, 2013

14.6K

CD64 binding potential does not translate into enhanced therapeutic efficacy for anti-IL-23 antibodies under

Joel F Cohen-Solal1, Calvin S Pohl2, Sheila M Cummings3

  • 1AbbVie Inc. Bioresearch Center, 100 Research Drive, Worcester, MA, 01605, USA. joel.cohensolal@abbvie.com.

Molecular Medicine (Cambridge, Mass.)
|March 28, 2026
PubMed
Abstract

No abstract available in PubMed .

Keywords:
CD64Crohn’s diseaseFc portionFcγRIGuselkumabInflammatory bowel diseasePsoriasisRisankizumabUlcerative colitisUstekinumab

More Related Videos

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis07:25

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis

Published on: May 4, 2017

18.3K
Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries08:49

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries

Published on: January 22, 2019

9.6K

Related Concept Videos